1AK4 | A:; B: | HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 CAPSID |
1AWQ | A: | CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) |
1AWR | A:; B:; C:; D:; E:; F: | CYPA COMPLEXED WITH HAGPIA |
1AWS | A: | SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) |
1AWT | A:; B:; C:; D:; E:; F: | SECYPA COMPLEXED WITH HAGPIA |
1AWU | A: | CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER) |
1AWV | A:; B:; C:; D:; E:; F: | CYPA COMPLEXED WITH HVGPIA |
1BCK | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN |
1CWA | A: | X-RAY STRUCTURE OF A MONOMERIC CYCLOPHILIN A-CYCLOSPORIN A CRYSTAL COMPLEX AT 2.1 ANGSTROMS RESOLUTION |
1CWB | A: | THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION FOR ITS ANOMALOUSLY HIGH IMMUNOSUPPRESSIVE ACTIVITY |
1CWC | A: | IMPROVED BINDING AFFINITY FOR CYCLOPHILIN A BY A CYCLOSPORIN DERIVATIVE SINGLY MODIFIED AT ITS EFFECTOR DOMAIN |
1CWF | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN |
1CWH | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN |
1CWI | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORIN |
1CWJ | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORIN |
1CWK | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2-S-METHYL)SARCOSINE CYCLOSPORIN |
1CWL | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORIN |
1CWM | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN |
1CWO | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORIN |
1FGL | A: | CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAG PROTEIN |
1M63 | C:; G: | CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN SHOWS COMMON BUT DISTINCT RECOGNITION OF IMMUNOPHILIN-DRUG COMPLEXES |
1M9C | A:; B: | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE COMPLEX. |
1M9D | A:; B: | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) O-TYPE CHIMERA COMPLEX. |
1M9E | A:; B: | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A COMPLEX. |
1M9F | A:; B: | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M COMPLEX. |
1M9X | A:; B:; E:; F: | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M,G89A COMPLEX. |
1M9Y | A:; B:; E:; F: | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,G89A COMPLEX. |
1MF8 | C: | CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH CYCLOSPORIN A AND HUMAN CYCLOPHILIN |
1MIK | A: | THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORIN: SYNTHESIS, BIOLOGICAL ACTIVITY, AND CRYSTALLOGRAPHIC ANALYSIS WITH CYCLOPHILIN A |
1NMK | A:; B: | THE SANGLIFEHRIN-CYCLOPHILIN INTERACTION: DEGRADATION WORK, SYNTHETIC MACROCYCLIC ANALOGUES, X-RAY CRYSTAL STRUCTURE AND BINDING DATA |
1OCA | A: | HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES |
1RMH | A:; B: | RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL |
1VBS | A: | STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDE |
1VBT | A:; B: | STRUCTURE OF CYCLOPHILIN COMPLEXED WITH SULFUR-SUBSTITUTED TETRAPEPTIDE AAPF |
1W8L | A: | ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES |
1W8M | A: | ENZYMATIC AND STRUCTURAL CHARACTERISATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES |
1W8V | A: | ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES |
1YND | A:; B: | STRUCTURE OF HUMAN CYCLOPHILIN A IN COMPLEX WITH THE NOVEL IMMUNOSUPPRESSANT SANGLIFEHRIN A AT 1.6A RESOLUTION |
1ZKF | A:; B: | CYRSTAL STRUCTURE OF HUMAN CYCLOPHILIN-A IN COMPLEX WITH SUC-AGPF-PNA |
2ALF | A:2-165 | CRYSTAL STRUCTURE OF HUMAN CYPA MUTANT K131A |
2CPL | A: | SIMILARITIES AND DIFFERENCES BETWEEN HUMAN CYCLOPHILIN A AND OTHER BETA-BARREL STRUCTURES. STRUCTURAL REFINEMENT AT 1.63 ANGSTROMS RESOLUTION |
2CYH | A: | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PRO |
2RMA | A:; C:; E:; G:; I:; K:; M:; O:; Q:; S: | CRYSTAL STRUCTURES OF CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A AND N-METHYL-4-[(E)-2-BUTENYL]-4,4-DIMETHYLTHREONINE CYCLOSPORIN A |
2RMB | A:; C:; E:; G:; I:; K:; M:; O:; Q:; S: | CRYSTAL STRUCTURES OF CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A AND N-METHYL-4-[(E)-2-BUTENYL]-4,4-DIMETHYLTHREONINE CYCLOSPORIN A |
2X2A | A:; B: | FREE ACETYL-CYPA TRIGONAL FORM |
2X2D | B:; C: | ACETYL-CYPA:HIV-1 N-TERM CAPSID DOMAIN COMPLEX |
3CYH | A: | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO |
3CYS | A: | DETERMINATION OF THE NMR SOLUTION STRUCTURE OF THE CYCLOPHILIN A-CYCLOSPORIN A COMPLEX |
3K0M | A: | CRYOGENIC STRUCTURE OF CYPA |
3K0N | A: | ROOM TEMPERATURE STRUCTURE OF CYPA |
3K0O | A: | ROOM TEMPERATURE STRUCTURE OF CYPA MUTANT SER99THR |
3K0P | A: | CRYOGENIC STRUCTURE OF CYPA MUTANT SER99THR |
3K0Q | A: | CRYOGENIC STRUCTURE OF CYPA MUTANT SER99THR (2) |
3K0R | A: | CRYOGENIC STRUCTURE OF CYPA MUTANT ARG55LYS |
3RDD | A: | HUMAN CYCLOPHILIN A COMPLEXED WITH AN INHIBITOR |
4CYH | A: | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO |
4IPZ | A: | SMBZ BOUND TO CYCLOPHILIN A |
5CYH | A: | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PRO |